Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial
Viola Andresen, Jürgen Gschossmann, Peter Layer
Topics & Concepts
Bifidobacterium bifidumMedicinePlaceboIrritable bowel syndromeTolerabilityInternal medicineClinical endpointClinical trialAbdominal painRandomized controlled trialGastroenterologyIntention-to-treat analysisRandomizationAdverse effectBifidobacteriumLactobacillusPathologyAlternative medicineGeneticsBacteriaBiologyGastrointestinal motility and disordersProbiotics and Fermented FoodsClostridium difficile and Clostridium perfringens research